BRCA Pathway: From Prevention to Treatment | 2025 BRCA Scientific Symposium
🛍️ Products Mentioned (1)
Stephanie Lheureux, MD, PhD, of the Princess Margaret Cancer Centre and the University of Toronto, discusses prevention and treatment for people with BRCA mutations at the 2025 Dana-Farber Cancer Institute Center for BRCA and Related Genes Scientific Symposium. For more information about the Center for BRCA and Related Genes, please visit https://www.dana-farber.org/cancer-care/treatment/brca-related-genes
🎬 More from Dana-Farber Cancer Institute
Understanding Chemo Neuropathy: A Webinar by the Older Adults with GI Cancer Program | Dana-Farber
19 views
Learning About Chronic Lymphocytic Leukemia | Lymph Notes: A Lymphoma Learning Series
112 views
ASCO26: David Reardon, MD Glioblastoma Vaccine | Dana-Farber Cancer Institute
106 views
Society of Gynaecological Oncology Congress 2026: Tara Berman, MD | Dana-Farber Cancer Institute
30 views
ASCO26: Julia Rotow, MD Silevertinib in Lung Cancer | Dana-Farber Cancer Institute
55 views
ASCO26: Atish Choudhury, MD, PhD A-DREAM/Alliance A032101 | Dana-Farber Cancer Institute
38 views